Search
for
Sort by
Research 181–210 of 579
- Mucocutaneous Manifestations of Endocrine Disorders
- Polycystic ovarian syndrome
- Novel Systematics of Nomenclature and Classification of Female Functional Androgenization (Including Polycystic Ovary Syndrome and Non-Classic Congenital Adrenal Hyperplasia)
- Dermatological problems of the puberty
- The skin as an endocrine organ
- Hyperandrogenism in PCOS
- Diagnosis, Manifestations, Laboratory Investigations, and Prognosis in Pediatric and Adult Cushing’s Disease in a Large Center in China
- The brain–gut–skin axis in inflammatory and disfiguring skin diseases: mechanistic insights, clinical correlations, and therapeutic strategies
- Restricted effects of androgens on glucocorticoid signaling in the mouse prefrontal cortex and midbrain
- Eyes open on stem cells
- Novel insights into the molecular mechanisms underlying generalized glucocorticoid resistance and hypersensitivity syndromes
- Organizational Effects of Estrogens and Androgens on Estrogen and Androgen Receptor Expression in Pituitary and Adrenal Glands in Adult Male and Female Rats
- Revisiting the role of melatonin in human melanocyte physiology: A skin context perspective
- Hair cortisol in drug-naïve first-episode individuals with psychosis
- Human Hair Graying Revisited: Principles, Misconceptions, and Key Research Frontiers
- Recent Advances in the Pathogenesis of Autoimmune Hair Loss Disease Alopecia Areata
- Protective Role of Melatonin and Its Metabolites in Skin Aging
- Alopecia areata: a comprehensive review of clinical, immunologic, and genetic perspectives
- Molecular Mechanisms and Targeted Therapeutics in Androgenetic Alopecia: From Signaling Pathways to Regenerative Approaches
- Effects of the Lexington LaserComb on hair regrowth in the C3H/HeJ mouse model of alopecia areata
- Do follicles matter? Testing the effect of follicles on hair cortisol levels
- Pathophysiology of Alopecia Areata in the Pediatric Patient
- Progesterone Promotes Anti-Anxiety/Depressant-like Behavior and Trophic Actions of BDNF in the Hippocampus of Female Nuclear Progesterone Receptor, but Not 5α-Reductase, Knockout Mice
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Recent advances in the molecular mechanisms causing primary generalized glucocorticoid resistance
- Neuroactive Steroids and Ethanol Exposure: Relevance to Ethanol Sensitivity and Alcohol Use Disorders Risk
- 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Attenuates the Adverse Effects of Glucocorticoids on Dermal Papilla Cells
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Indications for a brain‐hair follicle axis: inhibition of keratinocyte proliferation and up‐regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P
- ς<sub>1</sub>Receptor-Related Neuroactive Steroids Modulate Cocaine-Induced Reward